期刊
BRITISH JOURNAL OF HAEMATOLOGY
卷 154, 期 4, 页码 533-535出版社
WILEY
DOI: 10.1111/j.1365-2141.2011.08623.x
关键词
multiple myeloma; bevacizumab; thalidomide; vascular endothelial growth factor; angiogenesis
类别
资金
- NCI NIH HHS [N01 CM062209, N01CM62209, N01-CM-62209] Funding Source: Medline